Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Omnicell (OMCL) Research & Development (2016 - 2025)

Omnicell (OMCL) has disclosed Research & Development for 16 consecutive years, with $21.6 million as the latest value for Q2 2025.

  • On a quarterly basis, Research & Development rose 2.23% to $21.6 million in Q2 2025 year-over-year; TTM through Jun 2025 was $89.4 million, a 5.2% decrease, with the full-year FY2025 number at $88.7 million, down 1.92% from a year prior.
  • Research & Development was $21.6 million for Q2 2025 at Omnicell, up from $20.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $28.4 million in Q4 2022 to a low of $16.1 million in Q1 2021.
  • A 5-year average of $22.6 million and a median of $22.1 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: dropped 13.79% in 2021, then skyrocketed 55.66% in 2022.
  • Omnicell's Research & Development stood at $21.9 million in 2021, then increased by 29.47% to $28.4 million in 2022, then dropped by 5.61% to $26.8 million in 2023, then decreased by 2.9% to $26.0 million in 2024, then dropped by 17.15% to $21.6 million in 2025.
  • Per Business Quant, the three most recent readings for OMCL's Research & Development are $21.6 million (Q2 2025), $20.5 million (Q1 2025), and $26.0 million (Q4 2024).